dnl747
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 28, 2018 (NCT03757351)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05588843 | Phase 2 | Nov 25, 2022 | Sanofi |
| NCT04781816 | Phase 2 | Apr 1, 2021 | Sanofi |
| NCT04469621 | Phase 1 | Jul 17, 2020 | Sanofi |
| NCT03757325 | Phase 1 | Feb 13, 2019 | Denali Therapeutics Inc. |
| NCT03757351 | Phase 1 | Dec 28, 2018 | Denali Therapeutics Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 3 | 3 | 2 | 2020 |
| Denali Therapeutics Inc. | For profit | 2 | 2 | 1 | 2018 |
2 organizations
Page 1 / 1